| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $0.21 (Beat by $0.02) |
| EPS GAAP Actual | $0.21 (Beat by $0.02) |
| Revenue Actual | $1.16815B |
| Revenue Surprise | Beat by $1168.15M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.42 | 7.23 | 1.39509 | 1.44573 | 1 |
| Dec 2029 | 1.63 | 6.3 | 1.58294 | 1.68666 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12 | 0.12 | 1.16815B | 5.13% | 1168.15M |
| FQ2 2025 (Jun 2025) | 0.05 | 0.05 | 1.17977B | 4.34% | 1179.77M |
| FQ1 2025 (Mar 2025) | -0.24 | -0.24 | 1.12557B | 7.87% | 1125.57M |
| FQ4 2024 (Dec 2024) | 0.0237 | 0.0237 | 1.09785B | 9.84% | 1097.85M |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 1.10818B | 8.84% | 1108.18M |
| FQ2 2024 (Jun 2024) | 0.14 | 0.14 | 1.12852B | 14.45% | 1128.52M |
| FQ1 2024 (Mar 2024) | -0.0103 | -0.0103 | 1.03694B | 100% | 1036.94M |
| FQ4 2023 (Dec 2023) | 0.14 | 0.14 | 0.989818B | 5.96% | 989.82M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26124 | -- | 0.25375 | 0.26864 | 4 |
| FQ3 2027 (Sep 2027) | 0.37 | -- | 0.35543 | 0.38824 | 6 |
| FQ2 2027 (Jun 2027) | 0.34 | -- | 0.32661 | 0.35676 | 6 |
| FQ1 2027 (Mar 2027) | 0.09 | -- | 0.08645572 | 0.09443591 | 6 |
| FQ4 2026 (Dec 2026) | 0.23626 | -- | 0.22949 | 0.24295 | 2 |
| FQ3 2026 (Sep 2026) | 0.30978 | 61.26 | 0.29758 | 0.32505 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.33B | -- | 1.3B | 1.36B | 5 |
| FQ3 2027 (Sep 2027) | 1.34B | -- | 1.3B | 1.39B | 4 |
| FQ2 2027 (Jun 2027) | 1.35B | -- | 1.31B | 1.41B | 8 |
| FQ1 2027 (Mar 2027) | 1.28B | -- | 1.24B | 1.33B | 5 |
| FQ4 2026 (Dec 2026) | 1.25B | -- | 1.22B | 1.28B | 3 |
| FQ3 2026 (Sep 2026) | 1.27B | 7.77 | 1.23B | 1.31B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12 | 0.12 | 100% | |
| FQ2 2025 (Jun 2025) | 0.05 | 0.05 | 100% | |
| FQ1 2025 (Mar 2025) | -0.24 | -0.24 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0237 | 0.0237 | 100% | |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 100% | |
| FQ2 2024 (Jun 2024) | 0.14 | 0.14 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0103 | -0.0103 | 100% | |
| FQ4 2023 (Dec 2023) | 0.14 | 0.14 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.17B | $1168.15M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.18B | $1179.77M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.13B | $1125.57M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.1B | $1097.85M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.11B | $1108.18M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.13B | $1128.52M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.04B | $1036.94M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.99B | $989.82M | 100% |